Anifrolumab vs Tirzepatide

## Anifrolumab vs Tirzepatide: Overview

This comparison examines the pharmacological differences between **Anifrolumab** and **Tirzepatide**.

## Mechanism of Action

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Anifrolumab — N/A; Tirzepatide — 5 days.

## Chemical Properties

**Type**: Anifrolumab — Antibody; Tirzepatide — Protein.